RA839


CAS No. : 1832713-02-6

1832713-02-6
Price and Availability of CAS No. : 1832713-02-6
Size Price Stock
5mg $180 In-stock
10mg $240 In-stock
25mg $390 In-stock
50mg $585 In-stock
100mg $875 In-stock
200 mg Get quote
500 mg Get quote
We match the lowest price on market.

We offer a substantial discount on larger orders, please inquire via [email protected]

or Fax: (86)21-58955996

Inquiry for price and availability only. Please place your order via our email or fax.

Cat. No. : HY-110275
M.Wt: 452.57
Formula: C25H28N2O4S
Purity: >98 %
Solubility: DMSO : 100 mg/mL (ultrasonic)
Introduction of 1832713-02-6 :

RA839 is a selective Nrf2/ARE pathway agonist and non-covalent small molecule binder of Keap1 (Kd is approximately 6 μM). RA839 prevents inducible nitric oxide synthase expression and nitric oxide release. RA839 exerts anti-rotaviral and anti-inflammatory effects[1][2]. In Vitro:RA839 (5-20 μM) reduces LPS-induced NO release in BMDM in a concentration-dependent manner[1].
RA839 (5-40  μM) shows potent anti-rotaviral efficacy in RV-SA11 infected (12 hpi) MA104 cells, with reducing RV RNA and protein expressions, viroplasm formation[2].
In Vivo:RA839 (30 mg/kg, i.p.) modulates Nrf2 target genes in the context of reduced oxidative liver metabolism in mice, inducing hepatic mRNA levels of the prototypic Nrf2 target genes GCLC and NQO1[1].

Your information is safe with us.